Ultrasound Before Corticosteroid Injection for Arthritis
Official title: The Efficacy of Ultrasonication in Combination With Corticosteroid Intraarticular Injection for Arthritis
Run by Taichung Veterans General Hospital · NCT07363876 · Data updated 2026-11-12
This trial tests whether applying ultrasound before a corticosteroid joint injection helps improve arthritis symptoms in adults with limb arthritis who need an injection.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Taichung Veterans General Hospital Academic / other |
| Locations | 1 site (Taichung) |
| Status | Recruiting |
| Started | February 26, 2026 |
| Main results expected | November 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 30, 2026 |
| Trial ID | NCT07363876 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older with limb arthritis who require an intra-articular corticosteroid injection and have not had insufficient response or contraindication to oral anti-inflammatory meds.
✕Probably not a fit
Patients with prosthetic joints, hip involvement, gout, infectious arthritis, or cellulitis at the treatment site may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study will evaluate if therapeutic ultrasound applied prior to intra-articular corticosteroid injection improves outcomes for adults with limb arthritis. Participants must be 18 or older and have arthritis in a joint that requires injection, with exclusions including prosthetic joints, hip involvement, gout, infectious arthritis, or cellulitis at the treatment site. The study uses two interventions—therapeutic ultrasound followed by corticosteroid injection—and will monitor safety and treatment response. It is conducted at Taichung Veterans General Hospital in Taichung, Taiwan, and aims to determine if the combined approach yields better relief than injection alone.
Why it matters
Potential benefit: If successful, patients may experience greater pain relief and improved joint function from the combined treatment.
How similar studies have gone: Prior research in related musculoskeletal therapies supports ultrasound-enhanced drug delivery, but this specific combined approach is novel in this arthritis setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years or older. * Diagnosed with arthritis in the limbs. * Inadequate response to or contraindication for oral anti-inflammatory medications. * Assessed by a physician as requiring intra-articular corticosteroid injection. Exclusion Criteria: * History of joint replacement (prosthetic joint) in the affected area. * Hip joint involvement. * Diagnosis of gout. * Infectious arthritis. * Presence of cellulitis at the treatment site.
Where it's running
-
Taichung Veterans General Hospital
Taichung, Taiwan Recruiting
Study contacts
- Principal investigator: Kuo-Lung Lai, MD — Taichung Veterans General Hospital (TaichungVGH)
- Study coordinator: Kuo-Lung Lai, MD
- Email: kllaichiayi@yahoo.com.tw
- Phone: +886-4-2359-2525
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
Ultralow-dose PET scan to detect bone activity with 18F‑NaF
This trial tests whether a new high-sensitivity PET scan using a tiny amount of 18F‑sodium fluoride can produce clear bone images in adults with or without bone disease while cutting radiation exposure by 10–100 times.
-
Early stratification of acute arthritis
The project will collect clinical information and biomarker samples to try to find signs that help classify and guide treatment for adults who developed inflammatory arthritis symptoms within the past 12 weeks.
-
AI-guided precision immunotherapy for rheumatoid arthritis
This trial will see if adding the dnaJP1 peptide to hydroxychloroquine helps adults with moderately to severely active rheumatoid arthritis who have not used DMARDs or biologic treatments.
-
Biophoton therapy for chronic severe arthritis pain relief
This study is testing if biophoton therapy can help people with chronic severe arthritis pain feel better over 12 weeks.
-
Examining the effects of different exercise levels on arthritis symptoms
This study tests how different amounts of exercise can help people with arthritis feel better over six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.